StockData
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN) KPIs and segments

DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.84−0.08 (-0.81%)

Close on Nov 17, 2026Market cap $615.80MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Design Therapeutics's business

Coming soon

This tab will track the numbers specific to Design Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?